The latest lung cancer news.
Latest Cancer / Oncology News From Medical News Today.
Increase In Breast Cancer Among Alaska Native Women Appears To Be Slowing, Re...
The 30-year increase in breast cancer rates among Alaska Native women appears to be leveling off, according to researchers making a presentation on Tuesday at a cancer symposium in Anchorage, Alaska, the Anchorage Daily News reports.
Advanced Liver Cancer Patients Live Longer By Taking Anti Cancer Drug Sorafenib
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug. The findings, published in the July 23rd, 2008 issue of the New England Journal of Medicine, is a significant advance in the management of liver cancer, which is the third cause of cancer death globally, often resulting in death within a year of diagnosis.
VEGFbTM Has Been Granted Orphan Drug Designation By The FDA For The Treatment...
PhiloGene, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to VEGFb for the treatment of patients with advanced melanoma. This approval is for a larger subset of melanoma patients than was requested, and includes melanoma in stages IIb through IV.
Comparison Of Postoperative Pain, Convalescence, And Patient Satisfaction Bet...
UroToday.com - In this study of 58 laparoscopic cryoablations, 20 percutaneous cryoablations, and 15 percutaneous radiofrequency ablations for renal tumors averaging 2.2-2.6 cm., the percutaneous approaches resulted in statistically significant differences: shorter anesthesia time, shorter hospital stay, earlier return to no strenuous activity, and shorter time to full recovery.
Wilms' Tumor Associated With Vertebral Anomalies
UroToday.com - Dr. Serhan Kupeli, and his colleagues presented a case of a child who was diagnosed with Wilms' tumor. The child was given a thorough evaluation for tumor extension and was found to have several vertebral abnormalities. While they state that this is a rare association, they found a butterfly T3, T8 vertebrae and a T2, T7 hemivertebrae in the patient.
Tumor Growth Significantly Inhibited When Tumor Blood Flow Is Interrupted Fol...
Vascular disrupting agents (VDA) are a new class of anti-cancer drugs which obliterate all vessels in tumors and prevent nutrient supply to the tumor, thereby leading to necrosis of solid tumors. To clarify the therapeutic significance of interrupting tumor blood flow after radiotherapy, researchers administered a powerful VDA (AC7700), on rats after irradiation. AC770 completely destroyed the microcirculation at any time after the irradiation and inhibited tumor regrowth.
Immunotherapy With Leukemia-cell-derived Heat Shock Protein 70 Triggers Induc...
Even after chemotherapies and stem cell transplants, relapses still occur in leukemia patients. This study established a mouse model after bone marrow transplant and found that the immunization of mice with leukemia-cell-derived heat shock protein 70 (HSP) induced leukemia-specific immunities and prolonged their survival. The tumor-derived-HSP binds the tumor-specific antigenic peptides, making it an effective cancer vaccination.
Individual Tumorigenesis Pathways Of Sporadic Colorectal Adenocarcinomas Link...
Particular pathways of colorectal tumor growth are closely associated with characteristic pathologic features which, in turn, determine biological behaviors such as tumor growth, invasion and recurrence. This study compared data of 244 colorectal cancer patients who had curative surgery and examined their known genetic changes to determine the associated tumorgenesis pathways in sporadic colorectal cancer.
Cancer Institute Urges Caution With Cell Phones
A prominent US cancer institute has posted a notice on its website urging cell phone users to take precautions when using cell phones because advice from an international panel of experts says cell phones have not been around long enough for scientists to be sure about their safety.
Familial And Genetic Risk Of Transitional Cell Carcinoma Of The Urinary Tract
UroToday.com - Bladder cancer is the second most common genitourinary malignancy, and the incidence has continued to rise modestly since 1975. It occurs primarily in middle-aged men, and the majority of newly-diagnosed bladder cancers are low-grade, superficial, transitional cell carcinomas (TCCs).
Sound Pharmaceuticals Files Second IND With The FDA For The Prevention Of Che...
Sound Pharmaceuticals (SPI) has filed an Investigational New Drug Application with the FDA for the clinical testing of a proprietary formulation of ebselen for the prevention of chemotherapy induced hearing loss or ototoxicity. The oral capsule containing ebselen, SPI-3005, will be tested in advanced stage lung cancer and head and neck cancer patients receiving platinum based chemotherapy.
Roswell Park Surgeons Perform 100th Bladder Cancer Robotic Surgery
The Minimally Invasive Surgical Center at Roswell Park Cancer Institute (RPCI) has performed its 100th robot-assisted radical cystectomy for advanced bladder cancer using the da Vinci® Surgical Robotic System which distinguishes RPCI as one of the world's premier academic institutions for the procedure. Khurshid A.
Cancer Patient Survival Linked To The Checking Of More Lymph Nodes
Why do patients with gastric or pancreatic cancer live longer when they are treated at cancer centers or high-volume hospitals than patients treated at low-volume or community hospitals? New research from Northwestern University's Feinberg School of Medicine found that cancer patients have more lymph nodes examined for the spread of their disease if they are treated at hospitals performing more cancer surgeries or those designated as comprehensive cancer centers.
Merck Serono Receives European Approval For Broader Usage Of Erbitux In Metas...
Merck KGaA announced today that it has been granted approval by the European Commission for Erbitux® (cetuximab), to update its license for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type mCRC (metastatic colorectal cancer) in combination with chemotherapy, and as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecan.
St. Louis Post-Dispatch Examines Treatment Options For Pregnant Women With Ca...
The St. Louis Post-Dispatch on Sunday examined the "life-and-death" decisions pregnant women with cancer must make and the treatment options available to them. According to the Post-Dispatch, as many as one in every 1,000 pregnant women in the U.S. is diagnosed with cancer.
Newsfeed display by CaRP
